2009-2010 Influenza Season: Update for Pharmacists

September 30, 2009, 1:45 PM ET

Background information on influenza activity to date in the United States and information on how increased and possibly severe and prolonged activity this season may affect pharmacists;
An update on antiviral drug supplies;
Information about compounding an oral suspension from Tamiflu® 75mg capsules if commercially manufactured oral suspension formulation is not readily available and the ingredients needed to compound; and,
Information about the oral dosing dispenser provided with certain formulations of Tamiflu® oral suspension.

This document contains updated information:

Tamiflu® capsules 75 mg may be compounded using either of two vehicles: Cherry Syrup (Humco®) or Ora-Sweet® SF (sugar-free) (Paddock Laboratories).
As of September 29, 2009, these products may be in short supply in some locations if there is increased use in compounding of an oral suspension from Tamiflu 75mg capsules.
Additional information regarding the supply of these products is posted at the FDA website.
Paddock Laboratories reports that they have increased production of Ora-Sweet® SF and they are releasing new production daily to customers.
Humco® reports that they have increased production of Cherry Syrup and that they are releasing new production weekly to wholesalers. If pharmacists are having difficulty obtaining Humco® Cherry Syrup, they may contact Humco® directly to locate supplies at 1-800-662-3435.
CDC will provide additional information and updates as needed.

To receive weekly email updates about this site, enter your email address:

H1N1 Flu